Navalign LLC’s Corteva CTVA Stock Holding History

Navalign LLC’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-519	Closed	-$34.8K	–	201
2025 Q4	$34.8K	Buy	+519	New	+$33.6K	0.01%	218

Other funds holding CTVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Navalign LLC's CTVA Position: Q1 2026 in Review

Navalign LLC sold out of Corteva (CTVA) in Q1 2026, closing a stake of 519 shares — an estimated $34.8K sold.

Navalign LLC first reported a position in CTVA in Q4 2025 and held it in 1 quarter. The position peaked at $34.8K in Q4 2025. 1,480 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

Navalign LLC reported no remaining Corteva position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 519 Corteva shares in Q1 2026, an estimated $34.8K.
Navalign LLC first reported a position in Corteva in Q4 2025 and held it in 1 quarter.
Navalign LLC's Corteva position peaked at $34.8K in Q4 2025.
1,480 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.